Epigenetic compound Apigenin shows yet more anti-cancer benefits

2014 Research

We have covered Apigenin before in Cancer Watch.

A new study followed mice that were injected with ovarian cancer, in a form that is particularly resistant to chemotherapy. All the mice developed cancer. The study was funded by China’s National Natural Science Foundation and America’s National Cancer Institute.


An oral extract of apigenin was then administered at 75 mg/kg and 150 mg/kg, which respectively represented 0.025 per cent and 0.05 per cent of the total daily food intake of the mice.

At the conclusion of the study, the researchers concluded that oral administration of apigenin "inhibited ovarian tumor micrometastasis in liver, lung, small intestine and stomach in different degrees" and offered a "new rationale for apigenin in ovarian cancer prevention and treatment in the future."

Over the last nine years Apigenin (commonly found in artichoke, whole olives, celery and other foods) has been shown to effective against a number of cancers such as pancreatic, ovarian, liver, small intestine, stomach, lung and breast cancers.



2014 Research
CancerAcitve Logo
Subscribe (Free e-Newsletter)

Join Our
Newsletter

Join Our Newsletter Signup today for free and be the first to get notified on new updates.